Sort   by:  
 Page size 
UnknownSecond malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.

Purpose

Second malignant neoplasms (SMNs) after diagnosis of childhood acute lymphoblastic leukemia (ALL) are rare events.

Patients and methods

We analyzed data on risk factors and outcomes of 642 children with SMNs occurring after treatment for ALL from 18 collaborative study groups ...
S-EPMC3807139 | biostudies-literature
MetabolomicsImpact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepository

INTRODUCTION: Acute lymphoblastic leukemia (ALL) is among the most common cancers in children. With improvements in combination chemotherapy regimens, the overall survival has increased to over 90%. However, the current challenge is to mitigate adverse events resulting from the c...

2021-08-12 | MTBLS2394 | MetaboLights
UnknownChildhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.

Purpose

To review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and adolescents.

Methods

A review of English literature on childhood ALL focusing on collaborative studies was performed. The resulting arti...
S-EPMC4567699 | biostudies-literature
TranscriptomicsDNA methylation adds prognostic value to minimal residual disease status in pediatric T-cell acute lymphoblastic leukemia
Background: Despite increased knowledge about genetic aberrations in pediatric T-cell acute lymphoblastic leukemia (T-ALL), no clinically feasible treatment-stratifying marker exists at diagnosis. Instead patients are enrolled in intensive induction therapies with substantial side effects. In modern...
ORGANISM(S): Homo sapiens 
2016-03-30 | E-GEOD-69954 | biostudies-arrayexpress
Sort   by:  
 Page size